These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 7032292)

  • 61. Production of rat monoclonal antibodies specific for mouse integrins.
    Delcommenne M; Streuli CH
    Methods Mol Biol; 1999; 129():19-34. PubMed ID: 10494555
    [No Abstract]   [Full Text] [Related]  

  • 62. Human monoclonal antibodies produced against bovine thyroglobuline by in vitro immunization.
    Kockhans MC; Hentges F
    Bull Soc Sci Med Grand Duche Luxemb; 1988; 125(2):17-23. PubMed ID: 3242957
    [No Abstract]   [Full Text] [Related]  

  • 63. Experimental regulation of immunoglobulin synthesis and secretion in plasmacytoma and hybridoma cells.
    Lynch RG; Mathur A; Van Ness B
    Monogr Allergy; 1987; 22():204-11. PubMed ID: 3501834
    [No Abstract]   [Full Text] [Related]  

  • 64. Monoclonal antibodies and immunologic approaches to malignant tumors.
    Ng AK; Giacomini P; Ferrone S
    Adv Intern Med; 1983; 28():253-76. PubMed ID: 6340428
    [No Abstract]   [Full Text] [Related]  

  • 65. [Monoclonal antibodies in urology. Basic theories and clinical applications].
    Guiter J
    Ann Urol (Paris); 1985; 19(1):7-12. PubMed ID: 3885840
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Immunization of mice with DNA coding for the variable regions of anti-idiotypic antibody generates antigen-specific response.
    Vani J; Nayak R; Shaila MS
    Vaccine; 2007 Jun; 25(26):4922-30. PubMed ID: 17531360
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Monoclonal antibodies for diagnostic tests and affinity chromatography: a first step to antibody engineering.
    Schönherr OT; Roelofs H
    Dev Biol Stand; 1981; 50():235-42. PubMed ID: 7341293
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Isolation and properties of monoclonal antibodies to human erythrocytes].
    Petrosian MN; Mats AN; Ibragimov AR; Bogacheva GT; Rokhlin OV
    Dokl Akad Nauk SSSR; 1982; 267(4):1002-5. PubMed ID: 7151674
    [No Abstract]   [Full Text] [Related]  

  • 69. Carbohydrate and peptide specificity of MHC class II-restricted T cell hybridomas raised against an O-glycosylated self peptide.
    Jensen T; Hansen P; Galli-Stampino L; Mouritsen S; Frische K; Meinjohanns E; Meldal M; Werdelin O
    J Immunol; 1997 Apr; 158(8):3769-78. PubMed ID: 9103442
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Generation of monoclonal antibodies specific for human kallikrein 2 (hK2) using hK2-expressing tumors.
    Fisher TL; Nocera M; Willis RA; Turner MJ; Abdul Alim CS; Brown DM; Bourne PA; di Sant'Agnese PA; Messing EM; Lord EM; Frelinger JG
    Prostate; 2002 May; 51(3):153-65. PubMed ID: 11967950
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Production of marmoset monoclonal antibodies.
    Starr R; Wozniak A; Russ GR
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1034-5. PubMed ID: 2495589
    [No Abstract]   [Full Text] [Related]  

  • 72. Antibody engineering, a strategy for the development of monoclonal antibodies.
    Schönherr OT; Houwink EH
    Antonie Van Leeuwenhoek; 1984; 50(5-6):597-623. PubMed ID: 6099095
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical uses of monoclonal antibodies.
    Shuster J
    Clin Biochem; 1984 Apr; 17(2):108-11. PubMed ID: 6733893
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A comparison of spleen and lymph node cells as fusion partners for the raising of monoclonal antibodies after different routes of immunisation.
    Mirza IH; Wilkin TJ; Cantarini M; Moore K
    J Immunol Methods; 1987 Dec; 105(2):235-43. PubMed ID: 3320207
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Production and screening of monoclonal antibodies against HLA antigens].
    Ikewaki N; Tsuji K
    Nihon Rinsho; 1990 Feb; 48 Suppl():774-7. PubMed ID: 2355611
    [No Abstract]   [Full Text] [Related]  

  • 76. Lymphocyte hybridomas.
    Foster CS
    Cancer Treat Rev; 1982 Jun; 9(2):59-84. PubMed ID: 6751531
    [No Abstract]   [Full Text] [Related]  

  • 77. A human monoclonal antibody produced by in vitro sensitization of human lymphocytes with an antigen from urine of a sarcoma patient.
    Huth JF; Saxton RE; Morton DL; Irie RF
    J Surg Res; 1987 Jun; 42(6):591-6. PubMed ID: 3586628
    [No Abstract]   [Full Text] [Related]  

  • 78. Efficient generation of monoclonal antibodies from preselected antigen-specific B cells. Efficient immortalization of preselected B cells.
    Steenbakkers PG; Hubers HA; Rijnders AW
    Mol Biol Rep; 1994 Mar; 19(2):125-34. PubMed ID: 8072493
    [No Abstract]   [Full Text] [Related]  

  • 79. In vitro stimulation of immune spleen cells enhances the number of anti-lipid A-producing hybridomas.
    Erich T; Dekker B; De Beer M; Torensma R; Verhoef J
    J Immunol Methods; 1989 Mar; 118(1):17-24. PubMed ID: 2647854
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Establishment and characterization of monoclonal antibodies (TA75 and TA16) reactive with activated human T cells].
    Matsuo Y; Minato M; Takenaga M; Kajita T; Hori Y; Takamoto T; Yokoyama MM
    Nihon Ketsueki Gakkai Zasshi; 1986 Aug; 49(5):1037-46. PubMed ID: 3491483
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.